Royal Bank of Canada’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,171
| Closed | -$27K | – | 7246 |
|
|
2020
Q4 | $27K | Buy |
1,171
+271
| +30% | +$6.25K | ﹤0.01% | 5382 |
|
|
2020
Q3 | $9K | Sell |
900
-21
| -2% | -$210 | ﹤0.01% | 5488 |
|
|
2020
Q2 | $14K | Sell |
921
-53
| -5% | -$806 | ﹤0.01% | 5256 |
|
|
2020
Q1 | $12K | Sell |
974
-515
| -35% | -$6.35K | ﹤0.01% | 5284 |
|
|
2019
Q4 | $23K | Buy |
+1,489
| New | +$23K | ﹤0.01% | 5210 |
|